Your browser doesn't support javascript.
loading
Clinical experience with the combined use of recombinant interleukin-2 (IL2) and interferon alfa-2a (IFN alpha) in metastatic melanoma.
Kruit, W H; Goey, S H; Monson, J R; Stahel, R A; Calabresi, F; Mertelsmann, R; Holdener, E E; Eggermont, A M; Bolhuis, R L; de Mulder, P H.
Affiliation
  • Kruit WH; Rotterdam Cancer Institute, The Netherlands.
Br J Haematol ; 79 Suppl 1: 84-6, 1991 Oct.
Article de En | MEDLINE | ID: mdl-1931717
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Interleukine-2 / Interféron alpha / Mélanome Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Br J Haematol Année: 1991 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: Royaume-Uni
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Interleukine-2 / Interféron alpha / Mélanome Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Br J Haematol Année: 1991 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: Royaume-Uni